GRACEcast Lung Cancer Audio
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
- Update frequency
- every 7 days
- Average duration
- 15 minutes
- Episodes
- 136
- Years Active
- 2009 - 2013
ASCO 2012 LC Highlights: Dr. Mark Socinski on Single Agent vs Doublet Chemo for PS2 (audio)
Dr. Mark Socinski from the University of Pittsburgh reviews evidence to support doublet chemo over single agent for marginal performance status (PS2) patients with advanced NSCLC.
ASCO 2012 Lung Cancer Highlights: Dr. Mark Socinski on PARAMOUNT Continuation Maintenance Therapy Trial (audio)
Dr. Mark Socinski from the University of Pittsburgh reviews the survival benefit and implications from the PARAMOUNT maintenance therapy trial of Alimta (pemetrexed) in advanced NSCLC.
Immunotherapy for Lung Cancer: Q and A Session (audio)
Drs. Ramaswamy Govindan from Washington University and Julie Brahmer from Johns Hopkins University answer questions about the current evidence and emerging research on immune-based treatments for lun…
Immunotherapy for Lung Cancer: Yervoy, anti-PD-1, Reolysin, & Talactoferrin by Dr. J. Brahmer (audio)
Dr. Julie Brahmer reviews science and early trial results for immunotherapies for lung cancer ranging from cancer vaccines to anti-cancer viruses.
Immunotherapies for Lung Cancer: MAGE-A3, Stimuvax, and Lucanix, by Dr. R. Govindan (audio)
Dr. Ramaswamy Govindan provides a summary of the science behind several promising immunotherapies for lung cancer and the clinical trials that could lead to them being integrated into our treatment p…
Molecular Markers in Lung Cancer Pt 6: Dr. Glen Goss on Incorporating Markers Across a Health Care System (audio)
Dr. Glen Goss, University of Ottawa and NCI-Canada Lung Cancer Committee chair, discusses the potential and limitations of integrating molecular marker studies in advanced non-small cell lung cancer …
Molecular Markers in Lung Cancer Pt 5: Dr. David Spigel on Incorporating Targets into Clinical Trials (audio)
Dr. David Spigel, Sarah Cannon Cancer Center, discusses the benefits and challenges of conducting trials that include patient subgroups based on molecular markers.
Molecular Markers in Lung Cancer Pt 4: Broadening Use of Markers in Practice -- Panel Discussion (audio)
Panel discussion with 4 expert thought leaders in lung cancer about how we might best approach testing clinically relevant molecular targets in lung cancer patients.
Molecular Markers in Lung Cancer Pt 3: Who to Test and What to Test For -- Panel Discussion (audio)
Panel discussion with 4 expert thought leaders in lung cancer about the prevalence of critical molecular markers in different clinical and histologic groups of lung cancer patients.
Molecular Markers in Lung Cancer Pt 2: Dr. Alice Shaw on Mutation Patterns by Patient Features (audio)
Dr. Alice Shaw from Massachusetts General Hospital reviews the frequency of molecular markers in lung cancer by patient sex, smoking status, race, and histology.
Molecular Markers in Lung Cancer Pt 1: Dr. Charles Rudin on The Lung Cancer Mutation Consortium (audio)
Dr. Charles Rudin from Johns Hopkins covers the work from the Lung Cancer Mutation Consortium that identified a wide range of molecular markers in patients with lung adenocarcinoma.
Lung Cancer Highlights in 2011: Question and Answer Session with Dr. Jared Weiss (audio)
Q and A session with Dr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, about highlights in lung cancer in 2011.
Lung Cancer Highlights in 2011: Lung Cancer screening and Treating Advanced Lung Cancer in the Elderly (audio)
Dr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, reviews lung cancer highlights in 2011, here describing evidence supporting lung cancer screening by chest CT, as well as evidence on how best …
Lung Cancer Highlights in 2011: ALK and New Molecular Targets (audio)
Dr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, reviews lung cancer highlights in 2011, with this podcast focusing on ALK rearrangements and new molecular targets in lung cancer.
Lung Cancer Highlights in 2011: The EGFR Axis (audio)
Dr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, reviews lung cancer highlights in 2011, focusing here on treatments focusing on the EGFR axis.
Tips and Tools for Smoking Cessation, by Dr. Mark Millard (audio)
Dr. Mark Millard, Pulmonologist at Baylor University, describes how to approach smoking cessation and a range of tools for helping smokers who are motivated to quit.
A History of Tobacco and the Rise of Lung Cancer, by Dr. Mark Millard (audio)
Dr. Mark Millard, Pulmonologist at Baylor University, reviews the history of tobacco in North America, early research leading to the association of tobacco with lung cancer, and a discussion of how l…
Challenging Cases in Lung Cancer: Acquired Resistance to EGFR TKI Therapy in a Patient with an Activating EGFR Mutation (audio)
Case-based discussion with multiple lung cancer experts on optimal treatment of a patient with advanced lung adenocarcinoma, EGFR mutation, & now acquired resistance to EGFR TKI after very good prior…
Detection and Work-Up of Lung Nodules, by David Yankelevitz (audio)
Dr. David Yankelevitz, Professor of Radiology at Mount Sinai Medical Center in New York City, reviews technical advances in CT screening for lung nodules, features suggesting whether a nodule is ben…